Vaccine Patent Rights during the Covid-19 Pandemic as a Form of Justice in Protecting Human Rights

Abstract

The advent of the corona virus at the end of 2019 could not have been accidental, leaving nearly every country in the world. These fall into the category of non-natural disasters that pose a serious threat to human life as well as the economic sphere. The WHO finally declared it a pandemic. The pandemic boosted new products that had an intellectual property value: one of them was vaccine products. The rules for safeguarding intellectual property rights could lead to the practice of monopolizing knowledge by the pharmaceutical industry in developed countries. Since the pandemic is a global crisis, some countries demand an override or waiver the property rights of intellectual TRIPS (trade-related materials) on the key technologies of vaccine products. Covid-19 patent waiver is expected to be effective in leveling vaccines around the world. This is possible only with the efforts of developing countries to unpatent vaccine research and development in order to establish immunity to the corona virus.